Predictions
Affimed N.v.
Start price
Target price
Perf. (%)
€6.00
03.06.24
03.06.24
-
03.06.25
03.06.25
-21.50%
26.07.24
26.07.24
Good culture
Capable Management
Could be worthwhile Investment >10% per year
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€18.54
03.06.24
03.06.24
€20.28
03.06.25
03.06.25
8.17%
26.07.24
26.07.24
Americas Gold & Silver Corp.
Start price
Target price
Perf. (%)
€0.32
03.06.24
03.06.24
-
03.06.25
03.06.25
-28.73%
26.07.24
26.07.24
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Revenue growth >5% per year expected
Innovative
Cyclacel Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.34
01.06.24
01.06.24
-
01.06.25
01.06.25
-38.03%
25.07.24
25.07.24
Brockhaus Capital Mgmt AG
Start price
Target price
Perf. (%)
€27.40
31.05.24
31.05.24
-
31.05.25
31.05.25
10.66%
26.07.24
26.07.24
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€0.35
30.05.24
30.05.24
€55.39
30.05.25
30.05.25
-
13.02.24
13.02.24
Metasphere Labs Inc.
Start price
Target price
Perf. (%)
€3.08
30.05.24
30.05.24
-
30.05.25
30.05.25
-93.83%
26.07.24
26.07.24
Could be worthwhile Investment >10% per year
Birkenstock Holding Plc
Start price
Target price
Perf. (%)
€47.01
30.05.24
30.05.24
-
30.05.25
30.05.25
12.10%
26.07.24
26.07.24
Business model of the past or high risk
Probably not worthwhile Investment
Palomar Holdings Inc
Start price
Target price
Perf. (%)
€76.00
29.05.24
29.05.24
€91.47
29.05.25
29.05.25
5.92%
17.07.24
17.07.24
Palomar Holdings Inc
Start price
Target price
Perf. (%)
€74.00
29.05.24
29.05.24
€92.24
29.05.25
29.05.25
8.78%
17.07.24
17.07.24
Palomar Holdings Inc
Start price
Target price
Perf. (%)
€74.00
29.05.24
29.05.24
€88.48
29.05.25
29.05.25
8.78%
17.07.24
17.07.24
Apollo Global Management(new.)
Start price
Target price
Perf. (%)
€106.65
29.05.24
29.05.24
-
29.05.25
29.05.25
5.53%
26.07.24
26.07.24
Vertiv Holdings Co.
Start price
Target price
Perf. (%)
€97.50
28.05.24
28.05.24
€100.00
28.05.25
28.05.25
-27.15%
26.07.24
26.07.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Novo-nordisk As
Start price
Target price
Perf. (%)
€123.54
28.05.24
28.05.24
€135.00
28.05.25
28.05.25
-5.55%
26.07.24
26.07.24
Avalo Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
28.05.24
28.05.24
-
11.05.25
11.05.25
-2.92%
22.07.24
22.07.24
Ocugen Inc.
Start price
Target price
Perf. (%)
€1.63
26.05.24
26.05.24
€3.50
28.02.26
28.02.26
-7.44%
26.07.24
26.07.24
Could be very worthwhile Investment >20% year
Sagimet Biosciences Inc.
Start price
Target price
Perf. (%)
€4.38
26.05.24
26.05.24
€6.00
31.03.26
31.03.26
-34.25%
26.07.24
26.07.24
Could be very worthwhile Investment >20% year